An assessment of ultrasound guided foam sclerotherapy (UGFS) using the Aberdeen Varicose Vein Questionnaire (AVVQ).

Abstract

Aims: The effectiveness of ultrasound guided foam sclerotherapy (UGFS) on health-related quality of life (HRQL) in varicose vein treatment is unknown. We evaluated this using the Aberdeen Varicose Vein Questionnaire (AVVQ). Methods: 146 patients with venous disease of clinical severity class 1-6 completed the AVVQ prior to and 6-weeks after UGFS. Paired t-test analysis was performed. Results: Following UGFS there was a significant improvement in HRQL, assessed by AVVQ scoring: mean 20.1 ± SD 11.5 versus 15.3 ± SD 12.1 (p< 0.02). Improvements in pain in the right leg (0.58 vs. 0.31, p< 0.02) and left leg (0.64 vs. 0.4, p=0.007) and ability to perform daily activities (0.7 vs. 0.4, p<0.0001) were evident postoperatively. There was a significant reduction in pruritis bilaterally: right leg (1.3 vs. 0.5, p< 0.0001); left leg (1.0 vs. 0.6, p<0.008). Treatment led to a reduced concern over cosmetic appearance (2.88 vs. 1.91, p=0.0002) and choice of clothing (2.13 vs. 1.91, p=0.02). A significant reduction of analgesic usage, ankle swelling or stocking use was not demonstrated. Conclusion: UGFS is associated with significant improved functional performance and HRQL. A randomised control trial is indicated to compare the long-term clinical outcomes of UGFS with conventional techniques.